AGEN Insider Trading Activity and SEC Form 4 Filings
AGEN insider trading summary
No open-market insider purchases or sales of Agenus Inc (AGEN) have been reported on SEC Form 4 in the past 12 months.
Latest AGEN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 15, 2024 | Garo H Armen | See Remarks | Buy | $324K (500,000 @ $0.65) |
| Nov 15, 2023 | Ulf Wiinberg | Insider | Buy | $19K (25,000 @ $0.76) |
| Jan 6, 2022 | Steven J O'Day | Chief Medical Officer | Sell | $118K (38,679 @ $3.06) |
| Sep 13, 2021 | Garo H Armen | Chairman and CEO | Sell | $534K (82,107 @ $6.50) |
| Sep 10, 2021 | Christine M Klaskin | Pfo & Pao | Sell | $72K (11,120 @ $6.50) |
| Jun 17, 2020 | Incyte Corp | 10% Owner | Sell | $519K (141,920 @ $3.66) |
| Jun 16, 2020 | Incyte Corp | 10% Owner | Sell | $264K (72,080 @ $3.66) |
| Jun 15, 2020 | Incyte Corp | 10% Owner | Sell | $1.4M (384,025 @ $3.57) |
| Jun 12, 2020 | Incyte Corp | 10% Owner | Sell | $33K (9,100 @ $3.58) |
| Jun 11, 2020 | Incyte Corp | 10% Owner | Sell | $693K (183,875 @ $3.77) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.